Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts.

Blood Cancer J · 2024 · PMC11568287 · PMID 39548077

Europe PMC DOI

hedged sentence

0.1060

closest p · 2.1× alpha

0.1060

boldest claim

The sentences

showed a trendP = 0.106not close (p > 0.1)

For TP53 wt CK-AML, STAT3 inhibitor (S31-201) was the only potent compound that showed a trend towards sensitivity ( P = 0.106) (Fig. 1B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.